PET/CT to Image Hypoxia in Head and Neck Tumours
2 other identifiers
interventional
17
1 country
1
Brief Summary
Patients with head and neck cancer will be imaged with PET scan and CT scan in order to determine areas of the tumour that are hypoxic. It is hypothesized that PET /CT will provide information on hypoxia of the tumors and tumor regions in head and neck cancer patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for early_phase_1 head-and-neck-cancer
Started Nov 2006
Typical duration for early_phase_1 head-and-neck-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 1, 2006
CompletedFirst Posted
Study publicly available on registry
November 2, 2006
CompletedStudy Start
First participant enrolled
November 8, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2009
CompletedAugust 28, 2017
August 1, 2017
3.1 years
November 1, 2006
August 25, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
FDG/PET visualization of glycolysis/blood flow in tumors and intra-tumor regions;
2 years
Measurement of mRNAs levels encoding hypoxia response genes in tumor samples.
2 years
Interventions
All study participates will be scanned with PET/CT scan before surgery.
Eligibility Criteria
You may qualify if:
- All patients with head and neck tumours (\>3cm diameter) without bone involvement.
You may not qualify if:
- Known allergy to contrast agents
- Poor kidney function (serum creatinine level \> 2.0 mg/dL or 177 mmol/L)
- Pregnancy
- Breast-feeding
- Unable to lie supine
- Patient who were biopsied or operated upon within the past month.
- Patient who were treated with chemotherapy or radiation within the past month.
- Tumors that were obscured by artifacts (e.g. tooth fillings) in CT scans.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
London Health Science Center
London, Ontario, N6A 5W9, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John Yoo, MD
Dept. of Otolaryngology, London Health Science Center, London, Ontario, Canada
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 1, 2006
First Posted
November 2, 2006
Study Start
November 8, 2006
Primary Completion
November 30, 2009
Study Completion
December 31, 2009
Last Updated
August 28, 2017
Record last verified: 2017-08